Endocrine and immunologic effects of inhaled fluticasone propionate in healthy dogs

Journal of Veterinary Internal Medicine

Volumn 22, Issue 1, 2008, Pages 37-43

  Cohn, L A ^a,b   DeClue, A E ^a   Reinero, C R ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b Small Animal Internal Medicine   (United States)

Author keywords

Airway inflammation; Bronchitis; Glucocorticoid; Hypothalamic pituitary adrenal axis; Metered dose inhaler.

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

EID: 40549101383     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2007.0011.x     Document Type: Article

References (40)

1. 1 Kuehn NF. Chronic bronchitis in dogs. In: King LG, ed. Textbook of Respiratory Disease in Dogs and Cats, 1st ed. St Louis, MO: Saunders ; 2004: 379–387.
2. 2 McKiernan BC. Diagnosis and treatment of canine chronic bronchitis: Twenty years of experience. Vet Clin North Am ‐ Small Anim Pract 2000 ; 30: 1267–1278.
3. 3 Cohn LA. Glucocorticoids. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine, 6th ed. Philadelphia, PA: WB Saunders Co ; 2005: 503–508.
4. 4 Huang HP, Yang HL, Liang SL, et al. Iatrogenic hyperadrenocorticism in 28 dogs. J Am Anim Hosp Assoc 1999 ; 35: 200–207.
5. 5 Chastain CB, Graham CL. Adrenocortical suppression in dogs on daily and alternate‐day prednisone administration. Am J Vet Res 1979 ; 40: 936–941.
6. 6 Kemppainen RJ, Thompson FN, Lorenz MD. Use of a low dose synthetic ACTH challenge test in normal and prednisone‐treated dogs. Res Vet Sci 1983 ; 35: 240–242.
7. 7 Moore GE, Hoenig M. Duration of pituitary and adrenocortical suppression after long‐term administration of anti‐inflammatory doses of prednisone in dogs. Am J Vet Res 1992 ; 53: 716–720.
8. 8 Geller DE. Comparing clinical features of the nebulizer, metered‐dose inhaler, and dry powder inhaler. Resp Care 2005 ; 50: 1313–1321.
9. 9 Padrid P. Feline asthma. Diagnosis and treatment. Vet Clin North Am-Small Anim Pract 2000 ; 30: 1279–1293.
10. 10 Reinero CR, Brownlee L, Decile KC, et al. Inhaled flunisolide suppresses the hypothalamic–pituitary–adrenocortical axis, but has minimal systemic immune effects in healthy cats. J Vet Intern Med 2006 ; 20: 57–64.
11. 11 Couetil LL, Art T, De Moffarts B, et al. Effect of beclomethasone dipropionate and dexamethasone isonicotinate on lung function, bronchoalveolar lavage fluid cytology, and transcription factor expression in airways of horses with recurrent airway obstruction. J Vet Intern Med 2006 ; 20: 399–406.
12. 12 Kirschvink N, Leemans J, Delvaux F, et al. Inhaled fluticasone reduces bronchial responsiveness and airway inflammation in cats with mild chronic bronchitis. J Feline Med Surg 2006 ; 8: 45–54.
13. 13 Bexfield NH, Foale RD, Davison LJ, et al. Management of 13 cases of canine respiratory disease using inhaled corticosteroids. J Small Anim Pract 2006 ; 47: 377–382.
14. 14 Gulliver T, Eid N. Effects of glucocorticoids on the hypothalamic–pituitary–adrenal axis in children and adults. Immunol Allergy Clin North Am 2005 ; 25: 541–555.
15. 15 Priftis KN, Papadimitriou A, Gatsopoulou E, et al. The effect of inhaled budesonide on adrenal and growth suppression in asthmatic children. Eur Resp J 2006 ; 27: 316–320.
16. 16 Rush BR, Raub ES, Thomsen MM, et al. Pulmonary function and adrenal gland suppression with incremental doses of aerosolized beclomethasone dipropionate in horses with recurrent airway obstruction. J Am Vet Med Assoc 2000 ; 217: 359–364.
17. 17 Reinero CR, Decile KC, Byerly JR, et al. Effects of drug treatment on inflammation and hyperreactivity of airways and on immune variables in cats with experimentally induced asthma. Am J Vet Res 2005 ; 66: 1121–1127.
18. 18 Rush BR, Flaminio MJ, Matson CJ, et al. Cytologic evaluation of bronchoalveolar lavage fluid from horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. Am J Vet Res 1998 ; 59: 1033–1038.
19. 19 Georas SN. Inhaled glucocorticoids, lymphocytes, and dendritic cells in asthma and obstructive lung diseases. Proc Am Thorac Soc 2004 ; 1: 215–221.
20. 20 Miller GK, Valerio MG, Pino MV, et al. Chronic effects of the novel glucocorticosteroid RPR 106541 administered to beagle dogs by inhalation. Toxicol Pathol 2000 ; 28: 226–236.
21. 21 Guptill L, Scott‐Moncrieff JC, Bottoms G, et al. Use of the urine cortisol: Creatinine ratio to monitor treatment response in dogs with pituitary-dependent hyperadrenocorticism. J Am Vet Med Assoc 1997 ; 210: 1158–1161.
22. 22 Smiley LE, Peterson ME. Evaluation of a urine cortisol: Creatinine ratio as a screening test for hyperadrenocorticism in dogs. J Vet Intern Med 1993 ; 7: 163–168.
23. 23 Reimers TJ, Salerno VJ, Lamb SV. Validation and application of solid‐phase chemiluminescent immunoasssays for diagnosis of endocrine diseases in animals. Comp Haematol Int 1996 ; 6: 170–175.
24. 24 Johnson M. Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids. J Allergy Clin Immunol 1996 ; 97: 169–176.
25. 25 Hogger P, Rohdewald P. Binding kinetics of fluticasone propionate to the human glucocorticoid receptor. Steroids 1994 ; 59: 597–602.
26. 26 Hubner M, Hochhaus G, Derendorf H. Comparative pharmacology, bioavailability, pharmacokinetics, and pharmacodynamics of inhaled glucocorticosteroids. Immunol Allergy Clin North Am 2005 ; 25: 469–488.
27. 27 Tattersfield AE, Harrison TW, Hubbard RB, et al. Safety of inhaled corticosteroids. Proc Am Thorac Soc 2004 ; 1: 171–175.
28. 28 Graft DF. Finding the correct inhaled corticosteroid dose in asthma. Postgrad Med 2005 ; 117: 21–24.
29. 29 Fink RS, Pierre LN, Daley‐Yates PT, et al. Hypothalamic–pituitary–adrenal axis function after inhaled corticosteroids: Unreliability of urinary free cortisol estimation. J Clin Endocrinol Metab 2002 ; 87: 4541–4546.
30. 30 Pescollderungg L, Radetti G, Gottardi E, et al. Systemic activity of inhaled corticosteroid treatment in asthmatic children: Corticotrophin releasing hormone test. Thorax 2003 ; 58: 227–230.
31. 31 Pedersen S. Clinical safety of inhaled corticosteroids for asthma in children: An update of long-term trials. Drug Safety 2006 ; 29: 599–612.
32. 32 Martin RJ, Szefler SJ, Chinchilli VM, et al. Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Resp Crit Care Med 2002 ; 165: 1377–1383.
33. 33 Jasper DE, Jain NC. The influence of adrenocorticotropic hormone and prednisolone upon marrow and circulating leukocytes in the dog. Am J Vet Res 1965 ; 26: 844–850.
34. 34 Moore GE, Mahaffey EA, Hoenig M. Hematologic and serum biochemical effects of long‐term administration of anti‐inflammatory doses of prednisone in dogs. Am J Vet Res 1992 ; 53: 1033–1037.
35. 35 Trowald‐Wigh G, Hakansson L, Johannisson A, et al. The effect of prednisolone on canine neutrophil function: In vivo and in vitro studies. Acta Vet Scand 1998 ; 39: 201–213.
36. 36 Waters CB, Adams LG, Scott‐Moncrieff JC, et al. Effects of glucocorticoid therapy on urine protein‐to‐creatinine ratios and renal morphology in dogs. J Vet Intern Med 1997 ; 11: 172–177.
37. 37 Rinkardt NE, Kruth SA, Kaushik A. The effects of prednisone and azathioprine on circulating immunoglobulin levels and lymphocyte subpopulations in normal dogs. Can J Vet Res 1999 ; 63: 18–24.
38. 38 Cohn LA. The influence of corticosteroids on host defense mechanisms. J Vet Intern Med 1991 ; 5: 95–104.
39. 39 Rush BR, Raub ES, Rhoads WS, et al. Pulmonary function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. Am J Vet Res 1998 ; 59: 1039–1043.
40. 40 Duvivier DH, Votion D, Vandenput S, et al. Aerosol therapy in the equine species. Vet J 1997 ; 154: 189–202.